Palantir and OneMedNet Partner to Enhance Healthcare Data Platform with AI Technology.
ByAinvest
Monday, Oct 6, 2025 4:26 pm ET1min read
ONMD--
OneMedNet CEO Aaron Green stated, "Palantir's system revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." This partnership comes at a critical juncture as access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 2030. By leveraging Palantir's software, OneMedNet can combine its expansive provider network with Palantir's advanced analytics, unlocking scalable recurring revenue opportunities on a secure, regulatory-grade platform [1].
Under the multi-year agreement, Palantir's AI platform will integrate with OneMedNet's network, which provides access to more than 5 billion administrative claims and 131 million clinical exams across 1,750+ provider sites, spanning oncology, cardiology, and rare diseases. This integration will enable faster data discovery, accurate data delivery, and increased productivity, among other benefits [1].
Despite recent revenue declines, OneMedNet shares have risen over 100% in six months, reflecting investor confidence in the company's ability to leverage cutting-edge technology to drive growth and innovation in the healthcare sector. The partnership with Palantir Technologies is expected to further bolster OneMedNet's position in the market, as it continues to expand its market reach and independently broaden its global footprint [1].
PLTR--
OneMedNet has partnered with Palantir Technologies to enhance its healthcare data platform using Palantir's AI tools. The platform will deliver anonymized data to life sciences and research organizations, speeding up medical studies and product development. OneMedNet CEO Aaron Green said Palantir's system "revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." Despite recent revenue declines, OneMedNet shares have risen over 100% in six months.
OneMedNet Corporation has announced a strategic partnership with Palantir Technologies to enhance its healthcare data platform using Palantir's AI tools. This collaboration aims to deliver anonymized data to life sciences and research organizations, significantly speeding up medical studies and product development. The integration of Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's near real-time AI-powered provider network, enabling the company to empower life sciences, medical device, and research organizations with regulatory-grade clinical data and advanced analytics [1].OneMedNet CEO Aaron Green stated, "Palantir's system revolutionizes our ability to deliver high-quality, compliant data at remarkable speed." This partnership comes at a critical juncture as access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 2030. By leveraging Palantir's software, OneMedNet can combine its expansive provider network with Palantir's advanced analytics, unlocking scalable recurring revenue opportunities on a secure, regulatory-grade platform [1].
Under the multi-year agreement, Palantir's AI platform will integrate with OneMedNet's network, which provides access to more than 5 billion administrative claims and 131 million clinical exams across 1,750+ provider sites, spanning oncology, cardiology, and rare diseases. This integration will enable faster data discovery, accurate data delivery, and increased productivity, among other benefits [1].
Despite recent revenue declines, OneMedNet shares have risen over 100% in six months, reflecting investor confidence in the company's ability to leverage cutting-edge technology to drive growth and innovation in the healthcare sector. The partnership with Palantir Technologies is expected to further bolster OneMedNet's position in the market, as it continues to expand its market reach and independently broaden its global footprint [1].
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet